Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 17, 2026
Circulating tumor DNA in breast cancer: updates from SABCS 2025.
Journal: Journal of hematology & oncology
Published: February 08, 2026
Initiation and Completion of Hormone Therapy in Older Women With Early-Stage Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: May 09, 2025
Initiation and Completion of Endocrine Therapy in Older Women with Early-Stage Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: May 09, 2025
Multi-modal AI for comprehensive breast cancer prognostication.
Journal: Nature communications
Published: May 05, 2025
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Journal: Gynecologic oncology
Published: March 24, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 02, 2024
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Journal: Oncotarget
Published: April 10, 2023
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 24, 2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
Journal: European journal of medical research
Published: May 23, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).
Journal: Cancer medicine
Published: November 13, 2021
Last Updated: 09/26/2026